Cargando…
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms
Polycythemia vera (PV), essential thrombocythemia and primary myelofibrosis, are myeloproliferative neoplasms (MPNs) with distinct clinical features and are associated with the JAK2V617F mutation. To identify genomic anomalies involved in the pathogenesis of these disorders, we profiled 87 MPN patie...
Autores principales: | Rice, K L, Lin, X, Wolniak, K, Ebert, B L, Berkofsky-Fessler, W, Buzzai, M, Sun, Y, Xi, C, Elkin, P, Levine, R, Golub, T, Gilliland, D G, Crispino, J D, Licht, J D, Zhang, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256752/ https://www.ncbi.nlm.nih.gov/pubmed/22829077 http://dx.doi.org/10.1038/bcj.2011.39 |
Ejemplares similares
-
AKT is a therapeutic target in myeloproliferative neoplasms
por: Khan, Irum, et al.
Publicado: (2013) -
Targeting megakaryocytic induced fibrosis by AURKA inhibition in the myeloproliferative neoplasms
por: Wen, Qiang Jeremy, et al.
Publicado: (2015) -
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
por: Tefferi, A, et al.
Publicado: (2011) -
Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms
por: Bochicchio, Maria Teresa, et al.
Publicado: (2022) -
Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)